Ichor Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Ichor Biologics's estimated annual revenue is currently $14.9M per year.
- Ichor Biologics's estimated revenue per employee is $155,000
Employee Data
- Ichor Biologics has 96 Employees.
- Ichor Biologics grew their employee count by 19% last year.
Ichor Biologics's People
| Name | Title | Email/Phone |
|---|
Ichor Biologics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Ichor Biologics?
Ichor Biologics specializes in the development of therapeutic monoclonal antibodies to treat infectious diseases. Our company has developed a platform for characterizing and isolating pathogen-specific antibodies from convalescent patients. This platform allows us to preserve neutralizing and non-neutralizing antibody functions, thereby increasing the likelihood of in-vivo efficacy. Our initial disease targets include viral infections, such as Hantaviruses and HBV.
keywords:N/A
N/A
Total Funding
96
Number of Employees
$14.9M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.3M | 96 | 19% | $249.7M |
#2 | $24M | 96 | -11% | N/A |
#3 | N/A | 96 | 12% | $1000M |
#4 | $13.9M | 96 | 0% | N/A |
#5 | $14.4M | 96 | 25% | N/A |